 WALTHAM, Mass., May 19, 2022 GLOBE NEWSWIRE -- Checkpoint Therapeutics, Inc. Checkpoint NASDAQ: CKPT, a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright Global Investment Conference, on Wednesday, May 25, 2022, at 3:00 p.m. ET. Checkpoint management will also participate in one-on-one meetings during the conference. 